Jecko Thachil/LinkedIn
Nov 21, 2026, 11:16
Jecko Thachil: Optimizing Corticosteroid Therapy in ITP
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in eJHaem, adding:
“Corticosteroids are the first line treatment for immune thrombocytopenia.
But how do we decide on
- Dose
- Tapering
- Pred vs Dex
- Minimising toxicity
All and more detailed here
How We Use Corticosteroids in Immune Thrombocytopenia.”
Title: How We Use Corticosteroids in Immune Thrombocytopenia
Authors: Gerard Gurumurthy, Mervyn Morgan, Drew Provan, Jecko Thachil

Other posts featuring Jecko Thachil on Hemostasis Today.
-
Nov 21, 2026, 14:21Two Emerging Mechanisms Linking Sickle Cell Disease to Thrombosis
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:44Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research
-
Nov 21, 2026, 12:13Chaza Alaji: DVT in Early Pregnancy – Why Anticoagulation Decisions Matter
-
Nov 21, 2026, 12:06Salih Ehsan: Why Iron Therapy May Not Work
-
Nov 21, 2026, 11:59Edward Lee Carter: DOACs vs Warfarin for LV Thrombus – Are We Getting Closer to an Answer?